Literature DB >> 10491319

Cloning and characterization of the murine histone deacetylase (HDAC3).

U Mahlknecht1, D Hoelzer, R Bucala, E Verdin.   

Abstract

Histone acetylation modifiers have been described to participate as cofactors in mammalian transcriptional complexes involved in the regulation of cellular proliferation and differentiation. The acetylation of core histone proteins is reversible and regulated by two competing enzymatic activities, histone acetyltransferases (HATs) and histone deacetylases (HDACs). Increasing evidence suggests a connection between histone acetylation and the development of cancer and leukemia. We have recently mapped HDAC3 to mouse chromosome 18B3, a region which is syntenic with human chromosome 5q31, where HDAC3 is imbedded in a group of potential tumor suppressor genes and which has been reported to be the smallest commonly deleted segment in malignant myeloid disease. We report herein the identification and characterization of HDAC3, a yeast RPD3 ortholog in the mouse. Studies on murine HDAC3 may yield important insights on the understanding of myeloproliferative disease in humans. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10491319     DOI: 10.1006/bbrc.1999.1389

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4.

Authors:  Xiaohong Zhang; Yukiyasu Ozawa; Heehyoung Lee; Yu-Der Wen; Tse-Hua Tan; Brian E Wadzinski; Edward Seto
Journal:  Genes Dev       Date:  2005-04-01       Impact factor: 11.361

Review 2.  HDAC3 and the molecular brake pad hypothesis.

Authors:  Susan C McQuown; Marcelo A Wood
Journal:  Neurobiol Learn Mem       Date:  2011-04-16       Impact factor: 2.877

3.  Histone Deacetylase 3 Inhibition Decreases Cerebral Edema and Protects the Blood-Brain Barrier After Stroke.

Authors:  Hui Lu; Ryan Ashiqueali; Chin I Lin; Aashlesha Walchale; Victoria Clendaniel; Rudy Matheson; Marc Fisher; Eng H Lo; Magdy Selim; Amjad Shehadah
Journal:  Mol Neurobiol       Date:  2022-10-18       Impact factor: 5.682

4.  Modulation of splicing events in histone deacetylase 3 by various extracellular and signal transduction pathways.

Authors:  S G Gray; A H Iglesias; B T Teh; F Dangond
Journal:  Gene Expr       Date:  2003

5.  Histone deacetylase 3 localizes to the mitotic spindle and is required for kinetochore-microtubule attachment.

Authors:  Sumiyasu Ishii; Yasuhiro Kurasawa; Jiemin Wong; Li-Yuan Yu-Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-06       Impact factor: 11.205

6.  Neuroprotective Effects of Selective Inhibition of Histone Deacetylase 3 in Experimental Stroke.

Authors:  Rudy Matheson; Kohei Chida; Hui Lu; Victoria Clendaniel; Marc Fisher; Ajith Thomas; Eng H Lo; Magdy Selim; Amjad Shehadah
Journal:  Transl Stroke Res       Date:  2020-02-03       Impact factor: 6.800

7.  Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors.

Authors:  Elizabeth A Thomas
Journal:  Pharmaceuticals (Basel)       Date:  2014-05-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.